Strategic Growth Opportunities in the Clinical Oncology Next Generation Sequencing Market
The genomic oncology industry is experiencing significant transformation as healthcare systems adopt NGS technologies for precision cancer care. The Clinical Oncology Next Generation Sequencing NGS Market is valued at USD 7.32 billion in 2025 and projected to reach USD 20 billion by 2035 at a CAGR of 10.6%. This article explores strategic growth opportunities emerging across this...
0 Commentarios 0 Acciones 6 Views 0 Vista previa